Atlas FDA

OVATIO CRT SYSTEM

FDA premarket approval P060027 · decided 2008-05-15

Approval details

PMA number
P060027
Trade name
OVATIO CRT SYSTEM
Generic name
Defibrillator, automatic implantable cardioverter, with cardiac resynchronization (CRT-D)
Applicant
MicroPort CRM USA, Inc.
Date received
2006-10-02
Decision date
2008-05-15
Days to decision
591 days
Decision code
APPR
Product code
NIK
Advisory committee
Cardiovascular
Expedited review
No
Location
Arlington, TN
Statement
APPROVAL FOR THE OVATIO CRT-D SYSTEM. THE OVATIO CRT-D IS INDICATED FOR VENTRICULAR ANTITACHYCARDIA PACING AND VENTRICULAR DEFIBRILLATION FOR AUTOMATED TREATMENT OF LIFE THREATENING ARRHYTHMIAS. THE DEVICE IS ALSO INDICATED FOR THE REDUCTION OF HEART FAILURE SYMPTOMS IN MEDICALLY OPTIMIZED NYHA FUNCTIONAL CLASS III AND IV PATIENTS WITH LEFT VENTRICULAR EJECTION FRACTION OF 35% OR LESS, AND A QRS DURATION OF 150 MS OR LONGER. SITUS OTW LV LEAD IS DESIGNED TO PACE THE LEFT VENTRICLE THROUGH A CORO

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.